Acute effects of dietary fatty acids on osteclastogenesis via RANKL/RANK/OPG system

Molecular Nutrition and Food Research

Volumn 60, Issue 11, 2016, Pages 2505-2513

  Naranjo, M Carmen ^a   Garcia, Indara ^a   Bermudez, Beatriz ^b   Lopez, Sergio ^a   Cardelo, Magdalena P ^a   Abia, Rocio ^a   Muriana, Francisco J G ^a   Montserrat de la Paz, Sergio ^a  

^a INSTITUTO DE LA GRASA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Osteoclast; Osteoprotegerin; Postprandial state; RANKL; Triglyceride rich lipoprotein

Indexed keywords

FAT INTAKE; FATTY ACID; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPROTEIN; LIPOPROTEIN TRIGLYCERIDE; MONOUNSATURATED FATTY ACID; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNSATURATED FATTY ACID; VEGETABLE OIL;

BLOOD; DIET; DRUG EFFECTS; FAT INTAKE; HUMAN; MALE; MEAL; METABOLISM; OSTEOCLAST; PHARMACOLOGY; POSTPRANDIAL STATE;

DIET; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; LIPOPROTEINS; MALE; MEALS; OSTEOCLASTS; OSTEOPROTEGERIN; PLANT OILS; POSTPRANDIAL PERIOD; RANK LIGAND; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84983424610     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600303     Document Type: Article

References (33)

1. Lopez, S., Bermudez, B., Montserrat-de la Paz, S., Jaramillo, S. et al., Membrane composition and dynamics: a target of bioactive virgin olive oil constituents. BBA Biomembranes 2014, 1838, 1638–1656.
2. Varela, L. M., Ortega-Gomez, A., Lopez, S., Abia, R. et al., The effects of dietary fatty acids on the postprandial triglyceride-rich lipoprotein/apoB48 receptor axis in human monocyte/macrophage cells. J. Nutr. Biochem. 2013, 24, 2031–2039.
3. Chan, D. C., Pang, J., Romic, G., Watts, G. F., Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies. Curr. Atheroscler. Rep. 2013, 15, 309.
4. Cohn, J. S., Are we ready for a prospective study to investigate the role of chylomicrons in cardiovascular disease? Atheroscler. Suppl. 2008, 9, 15–18.
5. Lopez, S., Bermudez, B., Abia, R., Muriana, F. J. G., The influence of major dietary fatty acids on insulin secretion and action. Curr. Opin. Lipidol. 2010, 21, 15–20.
6. Varela, L. M., Ortega, A., Lopez, S., Bermudez, B. et al., in: Quiles, J.L., Ramirez-Tortosa, M. C., Yaqoob, P., Olive oil and Health, CABI publishing, Wallingford, UK 2006, pp. 351–370.
7. Alipour, A., Van Oostrom, A. J., Izraeljan, A., Verseyden, C. et al., Leukocyte activation by triglyceride-rich lipoproteins. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 792–797.
8. Crotti, T. N., Dharmapatni, A. A. S. S. K., Alias, E., Haynes, D. R., Osteoimmunology: major and costimulatory inflammatory induced bone loss. J. Immunol. Res. 2015, 2015, 281287.
9. Kalbasi Anaraki, P., Patecki, M., Tkachuk, S., Kiyan, Y. et al., Urokinase receptor mediates osteoclastogenesis via M-CSF release from osteoblasts and the c-Fms/PI3K/Akt/NF-κB pathway in osteoclasts. J. Bone Miner. Res. 2015, 30, 379–388.
10. Zhang, Y., Guan, H., Li, J., Fang, Z. et al., Amlexanox suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss. Sci. Rep. 2015, 5, 13575.
11. Sun, D., Krishnan, A., Zaman, K., Lawrence, R. et al., Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J. Bone Miner. Res. 2003, 18, 1206–1216.
12. Pérez de Ciriza, C., Moreno, M., Restituto, P., Bastarrika, G. et al., Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification. Clin. Biochem. 2014, 47, 272–278.
13. Zupan, J., Jeras, M., Marc, J., Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem. Med. 2013, 23, 43–63.
14. Varela, L. M., Bermudez, B., Ortega-Gomez, A., Lopez, S. et al., Postprandial triglyceride-rich lipoproteins promote invasion of human coronary artery smooth muscle cells in a fatty-acid manner through Pl3k-Rac1-JNK signalling. Mol. Nutr. Food Res. 2014, 58, 1349–1364.
15. EEC. Comision regulation (EEC) no. 796/02 of 6 May 2002 amending regulation EEC2568/91 on the characteristics of olive oil and olive residue oil and on the relevant methodology analysis. Off. J. Eur. Comm. 2002, L1 28, 8–28.
16. Montserrat-de la Paz, S., Naranjo, M. C., Bermudez, B., Lopez, S. et al., Postprandial dietary fatty acids exert divergent inflammatory response in retinal-pigmented epithelium cells. Food Func. 2016, 7, 1345–1353.
17. Montserrat-de la Paz, S., de la Puerta, R., Fernandez-Arche, A., Quilez, A. M. et al., Pharmacological effects of mitraphylline from Uncaria tomentosa in primary human monocytes: skew toward M2 macrophages. J. Ethnopharmacol. 2015, 170, 128–135.
18. Kurz, K., Herold, M., Russe, E., Klotz, W. et al., Effects of antitumor necrosis factor therapy on osteoprotegerin, neopterin and sRANKL concentrations in patients with rheumatoid arthritis. Dis. Markers 2015, 2015, 276969.
19. Lopez, S., Jaramillo, S., Varela, L. M., Ortega, A. et al., p38 MAPK protects human monocytes from postprandial triglyceride-rich lipoprotein-induced toxicity. J. Nutr. 2013, 143, 620–626.
20. Fernandez-Real, J. M., Bullo, M., Moreno-Navarrete, J. M., Ricard, W. et al., A Mediterranean diet enriched with olive oil is associated with higher serum total osteocalcin levels in elderly men at high cardiovascular risk. J. Clin. Endocrinol. Metab. 2012, 97, 3792–3798.
21. Sales, C., Oliviero, F., Spinella, R., The Mediterranean diet model in inflammatory rheumatic diseases. Reumatismo 2009, 61, 10–14.
22. Guasch-Ferre, M., Hu, F., Martinez-Gonzalez, M. A., Fito, M. et al., Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study. BMC Med. 2014, 12, 78.
23. Montserrat-de la Paz, S., Naranjo, M. C., Lopez, S., Abia, R. et al., Niacin and olive oil promote skewing to the M2 phenotype in bone marrow-derived macrophages of mice with metabolic syndrome. Food Funct. 2016, 7, 2233–2238.
24. Yang, J., Zhang, L., Yu, C., Yang, X. F. et al., Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark. Res. 2014, 2, 1.
25. Theoleyre, S., Wittrant, Y., Kwan-Tat, S., Fortun, Y. et al., The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004, 15, 457–475.
26. Lopez, S., Bermudez, B., Ortega, A., Varela, L. M. et al., Effects of meals rich in either monounsaturated or saturated fat on lipid concentrations and on insulin secretion and action in subjects with high fasting triglyceride concentrations. Am. J. Clin. Nutr. 2011, 93, 494–499.
27. Ortega, A., Varela, L. M., Bermudez, B., Lopez, S. et al., Dietary fatty acids linking postprandial metabolic response and chronic diseases. Food Funct. 2012, 3, 22–27.
28. Le, N. A., Lipoprotein-associated oxidative stress: a new twist to the postprandial hypothesis. Int. J. Mol. Sci. 2015, 16, 401–419.
29. Platt, I. D., Josse, A. R., Kendall, C. W. C., Jenkins, D. J. A. et al., Postprandial effects of almond consumption on human osteoclast precursors—an ex vivo study. Metabolism 2011, 60, 923–929.
30. Souza, P. P., Lerner, U. H., The role of cytokines in inflammatory bone loss. Immunol. Invest. 2013, 42, 555–622.
31. Akiyama, M., Nakahama, K., Morita, I., Impact of docosahexaenoic acid on gene expression during osteoclastogenesis in vitro—a comprehensive analysis. Nutrients 2013, 5, 3151–3162.
32. Kasonga, A. E., Deepak, V., Kruger, M. C., Coetzee, M., Arachidonic acid and docosahexaenoic acid suppress osteoclast formation and activity in human CD14+ monocytes, in vitro. PLoS One 2015, 10, e0125145.
33. Drosatos-Tampakaki, Z., Drosatos, K., Siegelin, Y., Gong, S. et al., Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it. J. Bone Miner. Res. 2014, 29, 1183–1195.